MoneyWorks4Me

Clarification sought from Alembic Pharmaceuticals

18 Apr 2016 Evaluate

The Exchange has sought clarification from Alembic Pharmaceuticals on April 18, 2016 with reference to the news appeared in www.indiainfoline.com stating, Alembic Pharma tanks 7% US FDA makes four observations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..